☆ 4.7 Article

Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice

NUTRIENTS (2023)

Related references

Note: Only part of the references are listed.

Article Biotechnology & Applied Microbiology

Downregulation of a mitochondrial micropeptide, MPM, promotes hepatoma metastasis by enhancing mitochondrial complex I activity

Man-Huan Xiao et al.

Summary: This study reveals that downregulation of MPM is associated with increased metastasis potential and recurrence in hepatocellular carcinoma. The restoration of MPM expression inhibits migration and invasion of hepatoma cells, while silencing MPM increases their metastasis ability. MPM interacts with NDUFA7 and regulates mitochondrial complex I activity and the NAD(+)/NADH ratio. miR-17-5p binds to MPM and suppresses its expression.

MOLECULAR THERAPY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting TGF-β signal transduction for fibrosis and cancer therapy

Dandan Peng et al.

Summary: TGF-beta plays essential roles in early embryonic development, organogenesis, immune regulation, tissue repair, and adult homeostasis. Its involvement in fibrosis and cancer is complex and context-dependent, showing both inhibitory and promoting effects. Therapeutics targeting TGF-beta signaling hold promise in treating fibrosis and cancer, although the development is hindered by potential systemic cytotoxicity.

MOLECULAR CANCER (2022)

Add to Collection

Review Oncology

Steps in metastasis: an updated review

Jamal Majidpoor et al.

Summary: Metastasis is a complex and deadly process involving various mechanisms and influencing factors. It can be targeted through strategies such as repressing pre-metastatic niche formation, suppressing environmental stressors, and targeting signaling pathways and cell types involved in the process.

MEDICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Nutrition & Dietetics

Advances in NAD-Lowering Agents for Cancer Treatment

Moustafa S. Ghanem et al.

Summary: NAD is essential for cancer cell survival and proliferation, making inhibition of its production pathway a promising anti-cancer strategy. Research has focused on targeting the key enzyme NAMPT, but clinical activity of inhibitors has been limited, indicating a need for refinement.

NUTRIENTS (2021)

Add to Collection

Article Gastroenterology & Hepatology

PPARα agonist fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and β-catenin signaling

Ashok Mandala et al.

Summary: Excessive hepatic iron accumulation leads to downregulation of PPARα-Sirt3-Wnt signaling pathway and promotes fibrosis progression. The PPARα agonist fenofibrate shows potential as a therapeutic drug for liver disorders associated with iron overload.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation

Keke Wu et al.

Summary: Nicotinamide mononucleotide (NMN) can attenuate cardiac fibrosis in vivo and fibroblast activation in vitro by suppressing oxidative stress and Smad3 acetylation in a NAD(+)/SIRT1-dependent manner.

LIFE SCIENCES (2021)

Add to Collection

Article Pharmacology & Pharmacy

Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma-Induced Cancer Cachexia

Jong Min Park et al.

Summary: Nicotinamide riboside (NR) intake can ameliorate cancer cachexia by inhibiting cachexic factors, muscle-specific ubiquitin-proteasome ligases, and adipose triglyceride lipase, while increasing crucial enzymes in NAD(+) biosynthesis.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting TGFβ signal transduction for cancer therapy

Sijia Liu et al.

Summary: TGF beta family members are cytokines with diverse effects on cell fate regulation during development and tissue homeostasis. Dysregulation of TGF beta signaling can lead to developmental disorders and diseases, including cancer. TGF beta plays a dichotomous role in cancer progression, acting as a tumor suppressor in early stages and a tumor promoter in late stages, with effects on proliferation, differentiation, apoptosis, metastasis, and the tumor microenvironment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration

Xiaolong Tang et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Review Nutrition & Dietetics

Nicotinamide Riboside-The Current State of Research and Therapeutic Uses

Mario Mehmel et al.

NUTRIENTS (2020)

Add to Collection

Article Anesthesiology

Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats

Marta Hamity et al.

PAIN (2020)

Add to Collection

Review Biochemistry & Molecular Biology

NAD+metabolism: pathophysiologic mechanisms and therapeutic potential

Na Xie et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Molecular principles of metastasis: a hallmark of cancer revisited

Jawad Fares et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Medicine, Research & Experimental

Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway

Rui Jiang et al.

LIFE SCIENCES (2019)

Add to Collection

Review Medicine, General & Internal

Hepatocellular Carcinoma

Augusto Villanueva

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

TGF--Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Yang Hao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Cell Biology

Modeling Human Cancer-induced Cachexia

Erin E. Talbert et al.

CELL REPORTS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

NAD+ repletion inhibits the endothelial-to-mesenchymal transition induced by TGF-β in endothelial cells through improving mitochondrial unfolded protein response

Minxue Zhang et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)

Add to Collection

Article Biochemical Research Methods

Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition

Weixuan Wang et al.

MOLECULAR & CELLULAR PROTEOMICS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway

Sufan Wang et al.

REDOX BIOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Cancer-associated cachexia

Vickie E. Baracos et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Review Oncology

NAD Metabolism in Cancer Therapeutics

Keisuke Yaku et al.

FRONTIERS IN ONCOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition

Weixuan Wang et al.

CELL CHEMICAL BIOLOGY (2018)

Add to Collection

Review Oncology

Cancer Cachexia: More Than Skeletal Muscle Wasting

Soren Fisker Schmidt et al.

TRENDS IN CANCER (2018)

Add to Collection

Article Gastroenterology & Hepatology

Nicotinamide Adenine Dinucleotide Biosynthesis Promotes Liver Regeneration

Sarmistha Mukherjee et al.

HEPATOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells

T. Ren et al.

ONCOGENE (2017)

Add to Collection

Article Oncology

Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer

Mingtong Ye et al.

JOURNAL OF CANCER (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells

Myung Jin Son et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2017)

Add to Collection

Review Oncology

Targeting TGF-β Signaling in Cancer

Selcuk Colak et al.

TRENDS IN CANCER (2017)

Add to Collection

Review Pharmacology & Pharmacy

NAD+ salvage pathway in cancer metabolism and therapy

Barry E. Kennedy et al.

PHARMACOLOGICAL RESEARCH (2016)

Add to Collection

Article Multidisciplinary Sciences

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

Samuel A. J. Trammell et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Add to Collection

Article Oncology

Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage

Krishna S. Tummala et al.

CANCER CELL (2014)

Add to Collection

Article Oncology

Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis

Lindsay E. Wu et al.

CANCER CELL (2014)

Add to Collection

Review Oncology

Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma

Gianluigi Giannelli et al.

CANCER RESEARCH (2014)

Add to Collection

Article Cell Biology

Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition

Rik Derynck et al.

CURRENT OPINION IN CELL BIOLOGY (2014)

Add to Collection

Article Genetics & Heredity

Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer

Antonio F. Santidrian et al.

DNA REPAIR (2014)

Add to Collection

Review Biochemistry & Molecular Biology

The pentose phosphate pathway and cancer

Krushna C. Patra et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Add to Collection

Review Oncology

Cancer cachexia: understanding the molecular basis

Josep M. Argiles et al.

NATURE REVIEWS CANCER (2014)

Add to Collection

Article Medicine, Research & Experimental

Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression

Antonio F. Santidrian et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Add to Collection

Review Biochemistry & Molecular Biology

TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD+METABOLITES

Samuel A. J. Trammell et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)

Add to Collection

Review Oncology

The NAD metabolome - a key determinant of cancer cell biology

Alberto Chiarugi et al.

NATURE REVIEWS CANCER (2012)

Add to Collection

Review Oncology

Definition and classification of cancer cachexia: an international consensus

Kenneth Fearon et al.

LANCET ONCOLOGY (2011)

Add to Collection

Review Biochemistry & Molecular Biology

NAD+/ NADH and NADP+/NADPH in cellular functions and cell death:: Regulation and biological consequences

Weihai Ying

ANTIOXIDANTS & REDOX SIGNALING (2008)

Add to Collection

Article Gastroenterology & Hepatology

Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice

Lin Jia et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Add to Collection

Review Oncology

Hypoxia, HIF1 and glucose metabolism in the solid tumour

Nicholas C. Denko

NATURE REVIEWS CANCER (2008)

Add to Collection

Article Gastroenterology & Hepatology

Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

H Imamura et al.

JOURNAL OF HEPATOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.